Diane Heiser

577 total citations
9 papers, 322 citations indexed

About

Diane Heiser is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Diane Heiser has authored 9 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Immunology. Recurrent topics in Diane Heiser's work include Cancer-related molecular mechanisms research (3 papers), RNA Research and Splicing (3 papers) and MicroRNA in disease regulation (2 papers). Diane Heiser is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), RNA Research and Splicing (3 papers) and MicroRNA in disease regulation (2 papers). Diane Heiser collaborates with scholars based in United States, Switzerland and Austria. Diane Heiser's co-authors include Andrew J. Gentles, Aaron M. Newman, Li Zhou, Shanique Martin, Susan M. Hiniker, Youngtae Jeong, Robert B. West, Ash A. Alizadeh, Henning Stehr and Justin N. Carter and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Diane Heiser

9 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane Heiser United States 6 230 96 87 80 32 9 322
Yu-Jia Shiah Canada 6 316 1.4× 84 0.9× 91 1.0× 99 1.2× 41 1.3× 6 447
Yunlim Kim South Korea 12 193 0.8× 93 1.0× 98 1.1× 59 0.7× 25 0.8× 24 334
Fujiang Xu China 7 180 0.8× 92 1.0× 96 1.1× 49 0.6× 31 1.0× 13 281
Marta Román Spain 5 168 0.7× 68 0.7× 126 1.4× 116 1.4× 23 0.7× 7 306
Ellen S. Hong United States 6 121 0.5× 58 0.6× 67 0.8× 77 1.0× 18 0.6× 11 219
Miljana Nenkov Germany 10 171 0.7× 125 1.3× 53 0.6× 64 0.8× 29 0.9× 12 267
Reham Helwa Egypt 9 210 0.9× 99 1.0× 49 0.6× 75 0.9× 48 1.5× 19 322
Beige Zong China 10 167 0.7× 119 1.2× 66 0.8× 125 1.6× 35 1.1× 15 321
Hongchao Tang China 10 171 0.7× 107 1.1× 49 0.6× 102 1.3× 55 1.7× 25 288
Naziha Mansuri Finland 8 123 0.5× 92 1.0× 83 1.0× 113 1.4× 46 1.4× 9 272

Countries citing papers authored by Diane Heiser

Since Specialization
Citations

This map shows the geographic impact of Diane Heiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Heiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Heiser more than expected).

Fields of papers citing papers by Diane Heiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Heiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Heiser. The network helps show where Diane Heiser may publish in the future.

Co-authorship network of co-authors of Diane Heiser

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Heiser. A scholar is included among the top collaborators of Diane Heiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Heiser. Diane Heiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bhagwat, Neha, Diane Heiser, Koichi Ito, et al.. (2022). Abstract 420: Combination of the MCL1 inhibitor PRT1419 and SMARCA2 degrader PRT3789 shows combinatorial benefit in SMARCA4 deleted lung cancer. Cancer Research. 82(12_Supplement). 420–420. 2 indexed citations
2.
Heiser, Diane, et al.. (2021). Evaluation of protein kinase D auto-phosphorylation as biomarker for NLRP3 inflammasome activation. PLoS ONE. 16(11). e0248668–e0248668. 6 indexed citations
3.
Heiser, Diane, P. Erbel, Achim Schlapbach, et al.. (2021). Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1. Biochemical and Biophysical Research Communications. 545. 177–182. 12 indexed citations
4.
Choudhary, Gaurav S., Nandini Ramachandra, Srabani Sahu, et al.. (2021). Preclinical Activity of the Clinical Stage Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor PRT543 in Splicing Mutant Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). Blood. 138(Supplement 1). 2597–2597. 3 indexed citations
5.
Jeong, Youngtae, Ngoc T. Hoang, Alexander F. Lovejoy, et al.. (2016). Role of KEAP1 / NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discovery. 7(1). 86–101. 243 indexed citations
6.
Heiser, Diane, Yee Sun Tan, Ian M. Kaplan, et al.. (2014). Correlated miR-mRNA Expression Signatures of Mouse Hematopoietic Stem and Progenitor Cell Subsets Predict “Stemness” and “Myeloid” Interaction Networks. PLoS ONE. 9(4). e94852–e94852. 6 indexed citations
7.
Heiser, Diane, et al.. (2012). Inferring MicroRNA Regulation of mRNA with Partially Ordered Samples of Paired Expression Data and Exogenous Prediction Algorithms. PLoS ONE. 7(12). e51480–e51480. 4 indexed citations
8.
Kaplan, Ian M., Sebastien Morisot, Diane Heiser, et al.. (2011). Deletion of Tristetraprolin Caused Spontaneous Reactive Granulopoiesis by a Non–Cell-Autonomous Mechanism Without Disturbing Long-Term Hematopoietic Stem Cell Quiescence. The Journal of Immunology. 186(5). 2826–2834. 23 indexed citations
9.
Keller, Mario, G. Burkard, Hans J. Bohnert, et al.. (1980). Transfer RNA genes associated with the 16S and 23S rRNA genes of Euglena chloroplast DNA. Biochemical and Biophysical Research Communications. 95(1). 47–54. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026